ライフサイエンスコーパス: window period

1 ng incidence by the length of the infectious window period.

2 determined for each MAA, including the mean window period.

3 ntigen (HBsAg) outside the preseroconversion window period.

4 portion of asymptomatic carriers during the window period.

5 ts, 780 (63%) answered the survey during the window period.

6 mical transitions and lags during the vernal window period and to understand how climate change may a

7 The subject was identified in the window period and was first infected with a complex ACD

8 llected house dust during all three critical window periods and analysed microbial composition using

9 ccuracy, the cost of the test, the infection window period, and how long it takes to receive the test

10 ticipants had viral load results outside the window period; and 254 (23.2%) did not have a viral load

11 lis, including diagnostic tests with shorter window periods, are urgently needed.

12 DNA are currently not identified during the window period before seroconversion.

13 ious HBV, along with HIV and HCV, during the window period before seroconversion.

14 d-1999 to identify donations made during the window period before seroconversion.

15 Infectivity for the recipient is high for window period blood and relatively low for OBIs.

16 ration of the preseroconversion NAT-positive window period (derived from analysis of frequent serial

17 has reduced the residual risk of infectious-window-period donations, such that per unit risks are <1

18 odent model because of the immunoincompetent window period during early marsupial development.

19 from screened blood units donated during the window period following a recent, undetected infection.

20 tion of HIV virus by Aptima, to estimate the window period for each test.

21 for the estimated duration of the infectious window period for each virus.

22 These findings demonstrate a window period for susceptibility to dual infection and i

23 New screening tests that shorten the window periods for the four viruses should reduce the ri

24 the basis of the incidence estimates and the window periods for these infections.

25 ood safety by reducing the antibody negative window period in blood donors in resource limited settin

26 ease transmission (IRD) accept a low risk of window period infection, yet those who decline must wait

27 rface protein (HBsAg) screening by detecting window period infections and 'occult' HBV infections (OB

28 resence of that infection, that is, the test window period, may benefit testing programs and clinicia

29 uggest that an approximately 200 ms temporal window (period of theta oscillation) segments the incomi

30 The MAA had a window period of 141 days (95% confidence interval [CI],

31 The HRM-based MAA had a mean window period of 154 days and provided cross-sectional i

32 the MAA to the BED-CEIA and to determine the window period of the MAA.

33 olving brain infarction during the potential window period of therapeutic opportunity in stroke.

34 the 11-day mouse group correlates with the "window period" of susceptibility observed in humans.

35 To parallel the "window period" of susceptibility to CHB in humans, 3 gro

36 had at least 15 of 20 lab results within the window period, our model predicted the results of the SA

37 had at least 15 of 20 lab results within the window period, our model predicted the results of the SA

38 e donor had no increased activity within the window period (P < 0.001).

39 mount of rain that falls during a 'migration window' period prior to potential egg release dates, whi

40 The 99(th) percentiles of the window period probability distribution ranged from 44 da

41 ns is compatible with estimates derived from window-period projections and recent measurements of inc

42 urrent serological methods, the assay offers window period reductions of 19 days prior to HBV surface

43 ted, based on SRTR data and meta-analyses of window period risks among persons with IRD behaviors.

44 During the highly infectious window period, the SP1 variant became detectable shortly

45 arly detection of plasma viremia during the "window period." Thus, the highly sensitive assay will be

46 e interval {CI}, .17%-9.33%], using a 14-day window period) was higher than the estimate based on ser

47 e risks of giving blood during an infectious window period were estimated as follows: for HIV, 1 in 4

48 titis B core antibody (IgM anti-HBc, for the window period when neither HBsAg nor anti-HBs is detecte

49 V, HCV) genomes uncovering preseroconversion window period (WP) infections for each virus and occult